Mumbai-based generic drug maker Piramal Healthcare Limited has completed its previously announced acquisition of Minrad International, a provider of generic inhalation anesthetics.
It may be noted that US-based Minrad had approved the deal at the special meeting of stock holders held on February 27.
Under the arrangement, holders of Minrad common stock will receive, in exchange for their shares, cash amount of US$0.12 per share.